Previsão

Comprar	1
Manter	0
Vender	0

Notícias Ir para o feed de notícias

Haleon publishes latest figures on share capital and voting rights

Haleon has announced that as of July 31, 2025, the company has a total of 8,987,651,560 issued ordinary shares, of which 3,880,205 are held as treasury shares. The total number of shares with voting rights therefore amounts to 8,983,771,355. This information serves as the basis for calculations in accordance with the transparency requirements of the Financial Conduct Authority. » Mais em de.investing.com
Haleon appoints new members to committees

Haleon has appointed Bláthnaid Bergin to the audit and risk committee and Matt Shattock to the environmental and social sustainability committee. The appointments took immediate effect and were made in accordance with UK listing rules. The announcement was published by company secretary Amanda Mellor. » Mais em de.investing.com
Haleon stock delivers 12.16 percent return over three years

An investment of £1,000 in Haleon three years ago would be worth £1,121.64 today, representing an increase of 12.16 percent. The calculation does not account for stock splits or dividends. Haleon was first listed on the stock exchange in July 2022 and currently has a market capitalization of £31.87 billion. » Mais em finanzen.net

Dividendos históricos Dividendos

Todos os indicadores de dividendos Todos os indicadores

Em 2026, Haleon PLC já distribuiu € 0,0563 em dividendos. A última distribuição ocorreu em maio.

Dados financeiros da empresa

No último trimestre, Haleon PLC registou receitas de € 3,19 bi e um ganho líquido de € 469,43 mi

(EUR)	junho de 2025	YoY
Receitas	3,19 bi	-
Ganho bruto	2,06 bi	-
Ganho líquido	469,43 mi	-
EBITDA	811,32 mi	-

Dados fundamentais

Métrica	Valor
Capitalização bolsista	€ 34,56 bi
Número de ações	8,81 bi
Máximo/mínimo de 52 semanas	€ 4,96 - € 3,58
Rentabilidade de dividendos	2,06%
Dividendos TTM	€ 0,0816
Próximo dividendo	€ 0,0279
Beta	0,24
PER (PE Ratio)	18,53
PEG (PEG Ratio)	3,15
P/VC (PB Ratio)	1,83
P/V (PS Ratio)	2,66

Perfil da empresa

Haleon plc beschäftigt sich mit der Forschung und Entwicklung, der Herstellung und dem Verkauf verschiedener Produkte für die Gesundheitsvorsorge in Nordamerika, Europa, dem Nahen Osten, Afrika, Lateinamerika und dem asiatisch-pazifischen Raum. Das Unternehmen bietet therapeutische Produkte in den Bereichen Mundgesundheit, Schmerzlinderung, Atemwegsgesundheit, Verdauungsgesundheit und andere Produkte sowie Vitamine, Mineralien und Nahrungsergänzungsmittel an. Zu seinem Markenportfolio gehören Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax und Centrum. Das Unternehmen war früher unter dem Namen DRVW 2022 plc bekannt und änderte im Februar 2022 seinen Namen in Haleon plc. Haleon plc wurde im Jahr 2021 gegründet und hat seinen Hauptsitz in Brentford, Vereinigtes Königreich.

Nome	Haleon PLC
CEO	Brian James McNamara
Sede	Weybridge, su Reino Unido
Site	haleon.com
Setor	Bens de consumo básico
Indústria	Produtos de higiene pessoal
Entrada em bolsa	18/07/2022
Colaboradores	24.561